110 related articles for article (PubMed ID: 1504417)
41. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
[TBL] [Abstract][Full Text] [Related]
42. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
Savoia D; Deplano C; Zucca M
Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
[TBL] [Abstract][Full Text] [Related]
43. Safety and immunogenicity of an oral inactivated whole-cell pseudomonas aeruginosa vaccine administered to healthy human subjects.
Cripps AW; Peek K; Dunkley M; Vento K; Marjason JK; McIntyre ME; Sizer P; Croft D; Sedlak-Weinstein L
Infect Immun; 2006 Feb; 74(2):968-74. PubMed ID: 16428742
[TBL] [Abstract][Full Text] [Related]
44. [IGA concentration in serum, sputum and bronchoalveolar lavage in chronic bronchitis].
Schultek T; Braun J; Wiessmann KJ; Wood WG
Dtsch Med Wochenschr; 1987 Oct; 112(42):1611-4. PubMed ID: 3665748
[TBL] [Abstract][Full Text] [Related]
45. [Therapy against intractable respiratory infections with Pseudomonas aeruginosa].
Nakata K
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):293-8. PubMed ID: 2515331
[TBL] [Abstract][Full Text] [Related]
46. Airway interleukin-8 in elderly patients with bacterial lower respiratory tract infections.
Ponglertnapagorn P; Oishi K; Iwagaki A; Sonoda F; Watanabe K; Nagatake T; Matsushima K; Matsumoto K
Microbiol Immunol; 1996; 40(2):177-82. PubMed ID: 8867615
[TBL] [Abstract][Full Text] [Related]
47. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
[TBL] [Abstract][Full Text] [Related]
48. Systemic exposure to Pseudomonal bacteria: a potential link between type 1 diabetes and chronic inflammation.
Peräneva L; Fogarty CL; Pussinen PJ; Forsblom C; Groop PH; Lehto M
Acta Diabetol; 2013 Jun; 50(3):351-61. PubMed ID: 22864910
[TBL] [Abstract][Full Text] [Related]
49. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response.
Johansen HK; Aanaes K; Pressler T; Nielsen KG; Fisker J; Skov M; Høiby N; von Buchwald C
J Cyst Fibros; 2012 Dec; 11(6):525-31. PubMed ID: 22595452
[TBL] [Abstract][Full Text] [Related]
50. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis.
Hoiby N; Flensborg EW; Beck B; Friis B; Jacobsen SV; Jacobsen L
Scand J Respir Dis; 1977 Apr; 58(2):65-79. PubMed ID: 404701
[TBL] [Abstract][Full Text] [Related]
51. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
52. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis.
Hancock RE; Mouat EC; Speert DP
J Infect Dis; 1984 Feb; 149(2):220-6. PubMed ID: 6421943
[TBL] [Abstract][Full Text] [Related]
53. Epidemiological analysis of serum anti-Pseudomonas aeruginosa PcrV titers in adults.
Yasumoto H; Katoh H; Kinoshita M; Shimizu M; Hamaoka S; Akiyama K; Naito Y; Sawa T
Microbiol Immunol; 2016 Feb; 60(2):114-20. PubMed ID: 26696420
[TBL] [Abstract][Full Text] [Related]
54. Immunoblot analysis of serological response to Pseudomonas aeruginosa septicaemia in man.
Matthews RC; Burnie JP; Tabaqchali S
J Clin Pathol; 1986 Dec; 39(12):1306-12. PubMed ID: 3100581
[TBL] [Abstract][Full Text] [Related]
55. Lung transplantation for non-cystic fibrosis bronchiectasis.
Rademacher J; Ringshausen FC; Suhling H; Fuge J; Marsch G; Warnecke G; Haverich A; Welte T; Gottlieb J
Respir Med; 2016 Jun; 115():60-5. PubMed ID: 27215505
[TBL] [Abstract][Full Text] [Related]
56. Aspects of serum and sputum antibody in chronic airways obstruction.
Clarke CW
Thorax; 1976 Dec; 31(6):702-7. PubMed ID: 1013941
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
[TBL] [Abstract][Full Text] [Related]
58. Local IgA production in patients with chronic bronchitis: effect of acute respiratory infection.
Stockley RA; Burnett D
Thorax; 1980 Mar; 35(3):202-6. PubMed ID: 7385092
[TBL] [Abstract][Full Text] [Related]
59. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
[TBL] [Abstract][Full Text] [Related]
60. Experimental immunization with Pseudomonas aeruginosa alginate induces IgA and IgG antibody responses.
Johansen HK; Høiby N; Pedersen SS
APMIS; 1991 Dec; 99(12):1061-8. PubMed ID: 1772641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
